TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli.

A clinical isolate of Escherichia coli, strain CB-134, recovered in 1986 from an abdominal abscess, exhibited resistance to penams, oxyimino-beta-lactams including broad-spectrum cephalosporins (cefotaxime, ceftriaxone, ceftazidime), and aztreonam but remained susceptible to cephamycins (cefoxitin,...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Paul, G C, Gerbaud, G, Bure, A, Philippon, A M, Pangon, B, Courvalin, P
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 1989
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC172795/
https://ncbi.nlm.nih.gov/pubmed/2692515
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items